Strategy and planning for chemopreventive drug development: Clinical development plans II
Tóm tắt
Từ khóa
Tài liệu tham khảo
, and Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute. In: , and (eds.) Cancer Chemoprevention. Boca Raton: CRC Press, 1992, pp. 41–56.
Kelloff, 1994, Cancer Epidemiol. Biomarkers Prev., 3, 85
Kelloff, 1994, Cancer Res., 54, 2015s
Kelloff, 1995, Cancer Epidemiol. Biomarkers Prev., 4, 1
Chanarin, 1994, Clin. Invest. Med., 17, 244
Childers, 1995, Cancer Epidemiol. Biomarkers Prev., 4, 155
Johnston, 1994, Cancer Res., 54, 5875
Goss, 1995, Clin. Cancer Res., 1, 287
Taylor, 1994, Cancer Res., 54, 2029s
National Toxicology Program (NTP). Toxicology and carcinogenesis studies of turmeric oleoresin (CAS No. 8024–37-1) (major component 79%–85% curcumin, CAS No. 458–37-7) in F344/N rats and B6C3F1 mice (feed studies). NTP Technical Report Series, No. 427, 1993.
Kelloff, 1994, J. Cell. Biochem., 20, 252
Kojima, 1994, Cancer Res., 54, 1446
Brown, 1995, Environ. Health Perspect., 103, 708
Goodman, 1992, Cancer Res., 52, 2752s